Fig. 3From: Silencing LncRNA SNHG16 suppresses the diabetic inflammatory response by targeting the miR-212-3p/NF-κB signaling pathwaySNHG16 and miR-212-3p predicted binding sites (a). Schematic representation of SNHG16 mutant sites (b). qRT-PCR demonstrated that miR-212-3p was upregulated in the HG and LPS states but that inflammatory factors were downregulated after transfection of the miR-212-3p mimic (c). Dual-luciferase gene reporter assay (d)Back to article page